Verstovsek, S <br/><br/>
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  08 2018 
 - 1880-1882 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdy173  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Eosinophilia--drug therapy<br/>Humans<br/>Lymphoma--drug therapy<br/>Male<br/>Middle Aged<br/>Myeloproliferative Disorders--drug therapy<br/>Oncogene Proteins, Fusion--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptor, Fibroblast Growth Factor, Type 1--antagonists & inhibitors<br/>Treatment Outcome